Tuberous Sclerosis: all 115 studies
Page 2 of 2. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- Tuberous Sclerosis Complex: Facial Angiofibroma Skin CreamCompletedNCT01853423Phase 1
- Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)CompletedNCT01780441
- Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSCCompletedNCT01767779
- Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis ComplexStatus unknownNCT01730209Phase 2/3
- A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComaWithdrawnNCT01690871Phase 2
- Studies of Autistic Patients: Gene Networks and Clinical SubtypesTerminatedNCT01092208
- Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)CompletedNCT01031901Phase 1
- Doxycycline In Lymphangioleiomyomatosis (LAM)CompletedNCT00989742Phase 4
- Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)CompletedNCT00792766Phase 1/2
- Tuberous Sclerosis Complex Natural History Study: Renal ManifestationsCompletedNCT00598455
- Effect of Fasting on the Size of Abdominal Lymphatic Tumors in WomenCompletedNCT00552955
- Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAMStatus unknownNCT00490789Phase 2
- RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAMCompletedNCT00457964Phase 1/2
- Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAMCompletedNCT00457808Phase 2
- Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)CompletedNCT00001869